189 related articles for article (PubMed ID: 33802239)
21. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.
Zeng J; Fan YJ; Tan B; Su HZ; Li Y; Zhang LL; Jiang J; Qiu FR
Acta Pharmacol Sin; 2018 Aug; 39(8):1393-1404. PubMed ID: 29417949
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
[TBL] [Abstract][Full Text] [Related]
23. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
Wang B; Yang S; Hu J; Li Y
J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466
[TBL] [Abstract][Full Text] [Related]
24. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
25. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
Yamazaki H; Shimada T
Xenobiotica; 1999 Mar; 29(3):231-41. PubMed ID: 10219964
[TBL] [Abstract][Full Text] [Related]
26. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
27. In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes.
Caggiano A; Blight A
J Drug Assess; 2013; 2(1):106-16. PubMed ID: 27536444
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of UDP-Glucuronosyltransferases (UGTs) Activity by constituents of Schisandra chinensis.
Song JH; Cui L; An LB; Li WT; Fang ZZ; Zhang YY; Dong PP; Wu X; Wang LX; Gonzalez FJ; Sun XY; Zhao DW
Phytother Res; 2015 Oct; 29(10):1658-64. PubMed ID: 26084208
[TBL] [Abstract][Full Text] [Related]
29. Mertansine Inhibits mRNA Expression and Enzyme Activities of Cytochrome P450s and Uridine 5'-Diphospho-Glucuronosyltransferases in Human Hepatocytes and Liver Microsomes.
Choi WG; Park R; Kim DK; Shin Y; Cho YY; Lee HS
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32131538
[TBL] [Abstract][Full Text] [Related]
30. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Cytochrome P450 by Propolis in Human Liver Microsomes.
Ryu CS; Oh SJ; Oh JM; Lee JY; Lee SY; Chae JW; Kwon KI; Kim SK
Toxicol Res; 2016 Jul; 32(3):207-13. PubMed ID: 27437087
[TBL] [Abstract][Full Text] [Related]
32. Dibenzocyclooctadiene Lignans from
Rybnikář M; Malaník M; Šmejkal K; Švajdlenka E; Shpet P; Babica P; Dall'Acqua S; Smištík O; Jurček O; Treml J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542438
[No Abstract] [Full Text] [Related]
33. Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes.
Nakashima A; Kawashita H; Masuda N; Saxer C; Niina M; Nagae Y; Iwasaki K
Xenobiotica; 2005 Jun; 35(6):589-602. PubMed ID: 16192110
[TBL] [Abstract][Full Text] [Related]
34. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of cytochrome P450 by ethambutol in human liver microsomes.
Lee SY; Jang H; Lee JY; Kwon KI; Oh SJ; Kim SK
Toxicol Lett; 2014 Aug; 229(1):33-40. PubMed ID: 24910189
[TBL] [Abstract][Full Text] [Related]
36. CYP2C19 is involved in the effect of Wuzhi tablet (
Yuan F; Liang X; Chen X; Qin X; Tan C; Wang L
Pharmazie; 2020 Nov; 75(11):559-564. PubMed ID: 33239129
[TBL] [Abstract][Full Text] [Related]
37.
Ding B; Ji X; Sun X; Zhang T; Mu S
Xenobiotica; 2020 Aug; 50(8):913-918. PubMed ID: 32026737
[TBL] [Abstract][Full Text] [Related]
38. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.
Kim S; Kim DK; Shin Y; Jeon JH; Song IS; Lee HS
Molecules; 2020 Oct; 25(19):. PubMed ID: 33050066
[TBL] [Abstract][Full Text] [Related]
39. Dibenzocyclooctadiene lignans from Schisandra chinensis protect primary cultures of rat cortical cells from glutamate-induced toxicity.
Kim SR; Lee MK; Koo KA; Kim SH; Sung SH; Lee NG; Markelonis GJ; Oh TH; Yang JH; Kim YC
J Neurosci Res; 2004 May; 76(3):397-405. PubMed ID: 15079869
[TBL] [Abstract][Full Text] [Related]
40. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
Kim SB; Kim KS; Kim DD; Yoon IS
Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
